Mode
Text Size
Log in / Sign up

Deep Learning Reconstruction EOB-MRI detects more small low-signal lesions than standard non-DL MRI in 53 patientsDeep Learning MRI Finds More Small Liver Lesions Than Standard Scans

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that DL Recon detects more small low-signal lesions than standard non-DL MRI in this small cohort.

This prospective, single-center study included 53 patients who underwent EOB-MRI during the hepatobiliary phase (HBP). The intervention was Deep Learning Reconstruction (DL Recon) EOB-MRI, compared against traditional Gd-EOB-DTPA-enhanced liver MRI (Standard Non-DL, HR Non-DL). The primary outcome was the detection of focal liver lesions (FLLs).

Regarding small low-signal lesions measuring 5–10 mm, the Standard DL group showed significantly more lesions than the Standard Non-DL group with a P value of 0.030. For high-signal lesions, no differences were observed across groups, with all other P values greater than 0.05. Similarly, no significant differences were found between groups for large low-signal lesions greater than 10 mm, where P was greater than 0.05.

Safety and tolerability data were not reported in this study. The total number of high-signal lesions showed a difference between Standard DL and Standard Non-DL with a P value of 0.048, though absolute numbers were not reported. Because this was a single-center study with a small sample size of 53 patients, the findings require cautious interpretation regarding broader clinical application.

This study looked at how different MRI techniques find spots in the liver. Researchers used a new method called Deep Learning Reconstruction and compared it to a standard, traditional scan method. They looked at scans from 53 patients who were in the hepatobiliary phase of the imaging process.

The main finding was that the deep learning method found more small lesions between 5 and 10 millimeters in size. The study reported a statistical difference with a p-value of 0.030 for these small spots. However, for larger lesions over 10 millimeters, both methods performed the same. There were no differences found for high-signal lesions either.

The researchers did not report any safety concerns or side effects from using the new scan technology. Because this was a single-center study with only 53 patients, the results come from a limited group. Readers should understand that this is early evidence from one location. More research is needed to see if these findings hold true in other hospitals or with larger groups of people.

What this means for you:
A new MRI method finds more small liver spots, but larger ones are seen equally well with standard scans.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedMay 2026
View Original Abstract ↓
ObjectiveIn recent years, the application of Deep Learning Reconstruction (DL Recon) technology in MRI has significantly improved the detection rate of small focal liver lesions (FLLs). This study aims to compare the detection performance of DL Recon EOB-MRI with traditional Gd-EOB-DTPA-enhanced liver MRI during the hepatobiliary phase (HBP) for FLL detection.MethodsThis prospective, single-center study included 53 patients who underwent EOB-MRI during the hepatobiliary phase (HBP). For each patient, four types of images were acquired: 3 mm thickness non-DL reconstruction (Standard Non-DL), 3 mm thickness DL reconstruction (Standard DL), 1 mm thickness non-DL reconstruction (HR Non-DL), and 1 mm thickness DL reconstruction (HR-DL). Lesions were categorized based on signal intensity into high-signal and low-signal types, and classified into five size groups: >30 mm, 20–30 mm, 10–20mm, 5–10mm, and 0.90, indicating excellent consistency (P < 0.001). For high-signal lesions, no differences were observed across groups (except for the total number of high-signal lesions: Standard DL vs. Standard Non-DL: P†† = 0.048, all other P > 0.05). For large low-signal lesions (>10 mm), no significant differences were found between groups (P > 0.05). For small low-signal lesions (5–10 mm), the Standard DL group showed significantly more lesions than the Standard Non-DL group (P†† = 0.030). For small low-signal lesions (
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.